Immunosuppression.
D000906:Antibodies; D000941:Antigens; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D001327:Autoimmune Diseases; D001665:Binding Sites; D002701:Chloramphenicol / Q000494:pharmacology; D003169:Complement Inactivator Proteins; D003609:Dactinomycin / Q000494:pharmacology; D004322:Drainage; D005493:Folic Acid Antagonists / Q000494:pharmacology; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control; D007106:Immune Sera; D007108:Immune Tolerance; D007166:Immunosuppressive Agents; D008197:Lymph Node Excision; D011687:Purines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D011827:Radiation; D013156:Splenectomy; D013897:Thoracic Duct; D013934:Thymectomy; D014181:Transplantation Immunology
D000906:Antibodies; D000941:Antigens; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D003169:Complement Inactivator Proteins; D005493:Folic Acid Antagonists; D007106:Immune Sera; D007166:Immunosuppressive Agents; D011687:Purines; D011743:Pyrimidines; D003609:Dactinomycin; D002701:Chloramphenicol